Urinary tract infection must be excluded in febrile infants less than 3 months of age with positive respiratory syncytial virus antigen test

2004 ◽  
Vol 44 (4) ◽  
pp. S126
Author(s):  
A.E. Muniz ◽  
S. Bartle ◽  
C. Woleben ◽  
R.L. Foster
Keyword(s):  
Urinary Tract Infection ◽  
Respiratory Syncytial Virus ◽  
Urinary Tract ◽  
Tract Infection ◽  
Virus Antigen ◽  
Antigen Test ◽  
Respiratory Syncytial Virus Antigen ◽  
Syncytial Virus

Testing for Urinary Tract Infection in the Influenza/Respiratory Syncytial Virus–Positive Febrile Infant Aged 2 to 12 Months

2017 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Anna Kathleen Schlechter Salinas ◽  
David S. Hains ◽  
Tamekia Jones ◽  
Camden Harrell ◽  
Mark Meredith
Keyword(s):  
Urinary Tract Infection ◽  
Respiratory Syncytial Virus ◽  
Urinary Tract ◽  
Tract Infection ◽  
Febrile Infant ◽  
Syncytial Virus

Efficacy of Ribavirin Aerosol Treatment for Respiratory Syncytial Virus Bronchiolitis in Infants

1987 ◽  
Vol 15 (4) ◽  
pp. 227-233 ◽  
Author(s):  
G. Caramia ◽  
E. Palazzini
Keyword(s):  
Respiratory Syncytial Virus ◽  
Body Temperature ◽  
Marked Improvement ◽  
Virus Antigen ◽  
The Body ◽  
Viral Agent ◽  
Nasal Wash ◽  
Respiratory Syncytial Virus Antigen ◽  
Syncytial Virus ◽  
Therapeutic Selectivity

The therapeutic efficacy of ribavirin, an anti-viral agent with a broad spectrum of activity, was studied in 14 infants with bronchiolitis which, in seven cases, was caused by a respiratory syncytial virus infection. The drug was administered for 5–6 days using an aerosol in periods of either 4 or 6 h with an interval of either 4 or 2 h between administrations. The body temperature of patients with fever returned to normal by day 3 of therapy. A significant decrease in the respiratory rate occurred by day 2 when there was also a marked improvement in the subjective and objective symptomatology. The most significant clinical improvements occurred in infants presenting a respiratory syncytial virus antigen in nasal wash specimens. This suggests therapeutic selectivity by ribavirin for (or a more pronounced sensibility of) this virus.

Sign in / Sign up

Export Citation Format

Share Document